CASE DISCUSSION
Diabetes Mellitus and its management
Presented United Arab Emirates by Dr.Ramkumar SundaraperumalViews
8,150
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Diabetes Mellitus is a chronic metabolic disorder characterized by high blood sugar levels due to either insufficient insulin production (Type 1) or insulin resistance (Type 2). Type 1 Diabetes is an autoimmune condition where the body's immune system attacks and destroys insulin-producing cells in...
Case Summary
- The webinar focuses on the management guidelines for type 2 diabetes, excluding discussions on type 1 diabetes, complications, and specific studies, aiming to provide a systematic approach to managing the condition within an hour. According to a Lancet article from June 2023, diabetes mellitus affects approximately 529 million people worldwide in 2021, with projections estimating it could reach 1.3 billion by 2050, the WHO guidelines indicates that nearly 1.5 million people died due to diabetes mellitus in the year 2021.
Speaker Profile
Dr.Ramkumar Sundaraperumal
HOD and Specialist Internal Medicine, Zulekha hospital, DubaiDr. Ramkumar Sundaraperumal is the Head of Department and Specialist in Internal Medicine at Zulekha Hospital Dubai.
He has extensive experience in diagnosing and managing a wide range of acute and chronic medical conditions in adult patients.
His clinical expertise includes diabetes, hypertension, infectious diseases, and complex multisystem disorders.
He is known for his patient-centric approach and emphasis on evidence-based internal medicine practice.
Through his leadership role, he contributes to advancing quality healthcare delivery and clinical excellence in hospital medicine.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.